646 related articles for article (PubMed ID: 32205232)
1. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).
Runfeng L; Yunlong H; Jicheng H; Weiqi P; Qinhai M; Yongxia S; Chufang L; Jin Z; Zhenhua J; Haiming J; Kui Z; Shuxiang H; Jun D; Xiaobo L; Xiaotao H; Lin W; Nanshan Z; Zifeng Y
Pharmacol Res; 2020 Jun; 156():104761. PubMed ID: 32205232
[TBL] [Abstract][Full Text] [Related]
2. Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
Ma Q; Pan W; Li R; Liu B; Li C; Xie Y; Wang Z; Zhao J; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Yang Z
Pharmacol Res; 2020 Aug; 158():104850. PubMed ID: 32360580
[TBL] [Abstract][Full Text] [Related]
3. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
[TBL] [Abstract][Full Text] [Related]
4. The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function.
Ding Y; Zeng L; Li R; Chen Q; Zhou B; Chen Q; Cheng PL; Yutao W; Zheng J; Yang Z; Zhang F
BMC Complement Altern Med; 2017 Feb; 17(1):130. PubMed ID: 28235408
[TBL] [Abstract][Full Text] [Related]
5. Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic.
Liang C; Hui N; Liu Y; Qiao G; Li J; Tian L; Ju X; Jia M; Liu H; Cao W; Yu P; Li H; Ren X
Phytomed Plus; 2021 May; 1(2):100027. PubMed ID: 35399819
[TBL] [Abstract][Full Text] [Related]
6. Broad antiviral and anti-inflammatory activity of Qingwenjiere mixture against SARS-CoV-2 and other human coronavirus infections.
Xie P; Fang Y; Shen Z; Shao Y; Ma Q; Yang Z; Zhao J; Li H; Li R; Dong S; Wen W; Xia X
Phytomedicine; 2021 Dec; 93():153808. PubMed ID: 34753027
[TBL] [Abstract][Full Text] [Related]
7. Perilla (Perilla frutescens) leaf extract inhibits SARS-CoV-2 via direct virus inactivation.
Tang WF; Tsai HP; Chang YH; Chang TY; Hsieh CF; Lin CY; Lin GH; Chen YL; Jheng JR; Liu PC; Yang CM; Chin YF; Chen CC; Kau JH; Hung YJ; Hsieh PS; Horng JT
Biomed J; 2021 Jun; 44(3):293-303. PubMed ID: 34119448
[TBL] [Abstract][Full Text] [Related]
8. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2.
Gendrot M; Andreani J; Jardot P; Hutter S; Delandre O; Boxberger M; Mosnier J; Le Bideau M; Duflot I; Fonta I; Rolland C; Bogreau H; La Scola B; Pradines B
Molecules; 2020 Oct; 25(21):. PubMed ID: 33142770
[TBL] [Abstract][Full Text] [Related]
10. Letter to the Editor in response to the articles 'Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)' and 'Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.'.
Huang X; Zhao Q; Xia L; Shi S
Pharmacol Res; 2021 Jan; 163():105289. PubMed ID: 33197600
[No Abstract] [Full Text] [Related]
11. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro.
Cao R; Hu H; Li Y; Wang X; Xu M; Liu J; Zhang H; Yan Y; Zhao L; Li W; Zhang T; Xiao D; Guo X; Li Y; Yang J; Hu Z; Wang M; Zhong W
ACS Infect Dis; 2020 Sep; 6(9):2524-2531. PubMed ID: 32786284
[TBL] [Abstract][Full Text] [Related]
12. Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms.
Marín-Palma D; Tabares-Guevara JH; Zapata-Cardona MI; Flórez-Álvarez L; Yepes LM; Rugeles MT; Zapata-Builes W; Hernandez JC; Taborda NA
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833991
[TBL] [Abstract][Full Text] [Related]
13. Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-κB signaling pathway in Influenza A virus-infected cells.
Zhou B; Yang Z; Feng Q; Liang X; Li J; Zanin M; Jiang Z; Zhong N
J Ethnopharmacol; 2017 Mar; 199():60-67. PubMed ID: 28119097
[TBL] [Abstract][Full Text] [Related]
14. Gallium maltolate has
Bernstein LR; Zhang L
Antivir Chem Chemother; 2020; 28():2040206620983780. PubMed ID: 33353394
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture.
Zhang YN; Zhang QY; Li XD; Xiong J; Xiao SQ; Wang Z; Zhang ZR; Deng CL; Yang XL; Wei HP; Yuan ZM; Ye HQ; Zhang B
Emerg Microbes Infect; 2020 Dec; 9(1):1170-1173. PubMed ID: 32432977
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.
Ma Q; Xie Y; Wang Z; Lei B; Chen R; Liu B; Jiang H; Wang Y; Liu Q; Yang Z
J Ethnopharmacol; 2021 Oct; 279():114367. PubMed ID: 34174375
[TBL] [Abstract][Full Text] [Related]
17. Antiviral Activity of the Propylamylatin
Brown AN; Strobel G; Hanrahan KC; Sears J
Viruses; 2021 Mar; 13(3):. PubMed ID: 33807769
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).
Softic L; Brillet R; Berry F; Ahnou N; Nevers Q; Morin-Dewaele M; Hamadat S; Bruscella P; Fourati S; Pawlotsky JM; Ahmed-Belkacem A
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32376613
[TBL] [Abstract][Full Text] [Related]
19. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo.
Müller C; Obermann W; Karl N; Wendel HG; Taroncher-Oldenburg G; Pleschka S; Hartmann RK; Grünweller A; Ziebuhr J
Antiviral Res; 2021 Feb; 186():105012. PubMed ID: 33422611
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo.
Deng W; Xu Y; Kong Q; Xue J; Yu P; Liu J; Lv Q; Li F; Wei Q; Bao L
Signal Transduct Target Ther; 2020 May; 5(1):66. PubMed ID: 32385228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
